# SLC6A1-NDD Prospective Longitudinal Natural History Study

> **NCT07531511** · — · NOT_YET_RECRUITING · sponsor: **UCB Biopharma SRL** · enrollment: 60 (estimated)

## Conditions studied

- SLC6A1 Neurodevelopmental Disorder (NDD)
- Developmental and Epileptic Encephalopathies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07531511
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2029-05-25
- **Final completion:** 2029-05-25
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07531511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07531511, "SLC6A1-NDD Prospective Longitudinal Natural History Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07531511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*